Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,620 | 53,084 | 60,653 | 68,012 | 75,807 |
| TOTAL | $46,909 | $53,348 | $61,036 | $68,595 | $75,996 |
| Non-Current Assets | |||||
| PPE Net | 32 | 42 | 52 | 64 | 75 |
| Other Non-Current Assets | 0 | 3,360 | 3,192 | 3,150 | 0 |
| TOTAL | $32 | $3,402 | $3,244 | $3,214 | $75 |
| Total Assets | $46,941 | $56,750 | $64,280 | $71,809 | $76,071 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,090 | 2,574 | 3,737 | 3,362 | 2,966 |
| Accrued Expenses | 834 | 402 | 348 | 547 | 586 |
| TOTAL | $2,924 | $2,976 | $4,085 | $3,909 | $3,552 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,924 | $2,976 | $4,085 | $3,909 | $3,552 |
| Shareholders' Equity | |||||
| Common Shares | 24 | 24 | 23 | 23 | 23 |
| Retained earnings | -273,064 | -262,257 | -254,875 | -246,172 | -240,529 |
| Other shareholders' equity | -380 | -380 | -380 | -380 | -380 |
| TOTAL | $44,017 | $53,774 | $60,195 | $67,900 | $72,519 |
| Total Liabilities And Equity | $46,941 | $56,750 | $64,280 | $71,809 | $76,071 |